本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Ikena Oncology, Inc.

1.13
+0.05004.63%
盤後1.10-0.0300-2.65%16:05 EDT
成交量:6.39萬
成交額:7.04萬
市值:5,453.17萬
市盈率:-1.11
高:1.15
開:1.08
低:1.06
收:1.08
資料載入中...
2025/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/03/06

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/10

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2024/12/23

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2024/12/23

重要事件披露

Form 8-K - Current report
2024/11/15

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/12

重要事件披露

Form 8-K - Current report
2024/06/10

重要事件披露

Form 8-K - Current report
2024/05/28

重要事件披露

Form 8-K - Current report
2024/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/03/12

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/12

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/21

重要事件披露

Form 8-K - Current report
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/19

重要事件披露

Form 8-K - Current report